Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;129(10):1345-50.
doi: 10.1001/archophthalmol.2011.142. Epub 2011 Jun 13.

Trends in glaucoma medication expenditure: Medical Expenditure Panel Survey 2001-2006

Byron L Lam  1 , D Diane Zheng, Evelyn P Davila, Kristopher L Arheart, Manuel A Ocasio, Kathryn E McCollister, Alberto J Caban-Martinez, David J Lee
Affiliations

Trends in glaucoma medication expenditure: Medical Expenditure Panel Survey 2001-2006

Byron L Lam et al. Arch Ophthalmol. 2011 Oct.

Abstract

Objective: To study trends of glaucoma medication expenditure from 2001 to 2006 using a nationally representative sample of US adults.

Methods: We analyzed glaucoma medication expenditure trends among participants of the 2001-2006 Medical Expenditure Panel Survey, a subsample of the National Health Interview Survey, which is a continuous multipurpose, multistage area probability survey of the US civilian noninstitutionalized population. After adjusting for survey design and inflation using the 2009 inflation index, data from 1404 participants 18 years and older using glaucoma medication were analyzed.

Results: Mean annual glaucoma medication expenditure per subject increased from $445 in 2001 to $557 in 2006 (slope = 20.8; P < .001). Subgroup analysis showed expenditure increased significantly in women (P = .02), those with public-only insurance (P < .001), and those with less than a high school education (P < .008). Over the survey period, a significant decrease in expenditures on β-blockers (P = .048) and significant increases in expenditures on prostaglandin analogs (P = .01) and α-agonists (P = .01) were found.

Conclusions: Factors associated with increasing glaucoma medication expenditure trends include the increasing use of prostaglandin analogs, changes in insurance coverage, and possibly more aggressive glaucoma treatment. The findings are pertinent to the development of cost-effective strategies that optimize treatment and reduce expenditures.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Plot of glaucoma medication expenditure overall and by sex, Medical Expenditure Panel Survey 2001–2006.
Figure 2.
Figure 2.
Plot of glaucoma medication expenditure by race, Medical Expenditure Panel Survey 2001–2006.
Figure 3.
Figure 3.
Plot of glaucoma medication expenditure for middle and older age groups, Medical Expenditure Panel Survey 2001–2006.
Figure 4.
Figure 4.
Plot of glaucoma medication expenditure by insurance type, Medical Expenditure Panel Survey 2001–2006.
Figure 5.
Figure 5.
Plot of glaucoma medication expenditure by medication class, Medical Expenditure Panel Survey 2001–2006. CAI indicates carbonic anhydrase inhibitor.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Facts about glaucoma. National Eye Institute Web site. http://www.nei.nih.gov/health/glaucoma/glaucoma_facts.asp. Accessed January 22, 2010.
    1. Congdon N, O’Colmain B, Klaver CC, et al.; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–485. - PubMed
    1. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124(12):1754–1760. - PubMed
    1. Hejkal TW, Camras CB. Prostaglandin analogs in the treatment of glaucoma. Semin Ophthalmol. 1999;14(3):114–123. - PubMed
    1. Singh K, Lee BL, Wilson MR; Glaucoma Modified RAND-Like Methodology Group. A panel assessment of glaucoma management: modification of existing RAND-like methodology for consensus in ophthalmology, part II. results and interpretation. Am J Ophthalmol. 2008;145(3):575–581. - PubMed

Publication types

Substances